Your only malignant mesothelioma news source!
Click on each item to read full story.

 
Aduro Presents Updated Interim Results from Phase 1b Clinical Trial in Mesothelioma at International Mesothelioma ...
read story
Aduro BioTech, Inc., a leader in cancer immunotherapy, today announced the presentation of updated safety and efficacy data from an ongoing Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma .
 
Press Release
read story
Aduro BioTech Inc. a leader in cancer immunotherapy today announced the presentation of updated safety and efficacy data from an ongoing Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma (MPM). Of 16 evaluable patients with response data 75% (12/16) had confirmed durable partial ...
 
Mesothelioma Compensation Center Urges Victims Of Mesothelioma To Call Them For Instant Access To The Nation's Best ...
read story
The Mesothelioma Compensation Center is urging just diagnosed victims of malignant mesothelioma or their family members to call them at 866-714-6466 for instant access to the nation's best mesothelioma compensation attorneys and a detailed conversation about vital issues that must be dealt with immediately, such as power of attorney. The group is focusing on how to write a will this week and ...
 
The Mesothelioma Compensation Center Urges Family Members of Diagnosed Victims of Malignant Mesothelioma to Take Wills ...
read story
WASHINGTON, Oct. 7, 2014 /PRNewswire/ -- The Mesothelioma Compensation Center is urging diagnosed victims of malignant mesothelioma or their family members to call them at 866-714-6466 as soon as possible after the actual diagnosis in order to ensure they have instant access to the nation's best mesothelioma compensation attorneys. This week the group is sharing a recent CNN Money article on the ...
 
Verastem Presents New Data on Mesothelioma Programs at the 12th International Mesothelioma Interest Group Meeting
read story
Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the presentation of clinical and p
 
The Mesothelioma Victims Center Explains Mesothelioma and Why Proper Diagnosis Is Essential to Receiving Possible ...
read story
WASHINGTON, Oct. 17, 2014 /PRNewswire/ -- The Mesothelioma Victims Center says, "Every month we get at least a dozen calls from family members wondering if their deceased loved one could have had mesothelioma, and if there could be compensation without an actual diagnosis—the answer is no. If a medical doctor suggests mesothelioma is a possibility for a loved one, please call 866-714-6466 ...
 
New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma
read story
Japanese doctors say they may have found a way around the toxicity problem of standard drug treatment for mesothelioma. (PRWeb October 25, 2014) Read the full story at http://www.prweb.com/releases/2014/10/prweb12272045.htm
 
Mesothelioma: New Findings On Treatment Options
read story
Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to new data from a prospective randomized phase II trial.
 
Mesothelioma Compensation Center Responds to Recent Article, Addresses Issues Surrounding Future of Mesothelioma ...
read story
WASHINGTON, Oct. 20, 2014 /PRNewswire/ -- The Mesothelioma Compensation Center has been hearing from full-time mesothelioma compensation attorneys nationwide for about a year related to how much longer the mesothelioma compensation trusts will remain properly funded and is commenting on a recent article from the Huffington Post. The group discusses how the loss of funds may not impact current ...
 
PD-L1 protein could be a potential immunotherapy target for malignant pleural mesothelioma
read story
Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presented at ESMO 2014 Congress in Madrid.